Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
Rochester, MN
This phase I trial studies the side effects and the best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.